Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.
Medical payments (“med pay”) coverage is a part of many commercial premises liability policies. Typically, med pay covers reasonable medical expenses, regardless of fault, up to a specified limit (usually between $1,000 and $10,000) if someone is hurt on the policyholder's premises.
Med pay coverage is usually purchased for good will purposes. It is hoped that if an injured person's medical expenses are paid, it will deter the injured person from instituting a lawsuit. To illustrate: Suppose a customer slips and falls while shopping at a store and incurs medical expenses. Because med pay coverage is applicable regardless of fault, the store can arrange for its customer's medical expenses to be paid under the med pay provisions in the store's liability policy. This way, through its show of good will, the store can avoid an acrimonious exchange with the customer ' or a lawsuit ' concerning whether the slip and fall was the store's fault.
Why is it that those who are best skilled at advocating for others are ill-equipped at advocating for their own skills and what to do about it?
There is no efficient market for the sale of bankruptcy assets. Inefficient markets yield a transactional drag, potentially dampening the ability of debtors and trustees to maximize value for creditors. This article identifies ways in which investors may more easily discover bankruptcy asset sales.
The DOJ's Criminal Division issued three declinations since the issuance of the revised CEP a year ago. Review of these cases gives insight into DOJ's implementation of the new policy in practice.
Active reading comprises many daily tasks lawyers engage in, including highlighting, annotating, note taking, comparing and searching texts. It demands more than flipping or turning pages.
With trillions of dollars to keep watch over, the last thing we need is the distraction of costly litigation brought on by patent assertion entities (PAEs or "patent trolls"), companies that don't make any products but instead seek royalties by asserting their patents against those who do make products.